Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Eli Lilly has stated it "remains confident in the differentiated benefits of tirzepatide." Facing generic competition, Novo Nordisk has taken several steps: Launch of rebranded versions In December 2025, Health Canada approved two Novo Nordisk rebranded versions on December 22: These are identical to the branded versions but come in different packaging
Retatrutide is an advanced weight loss peptide that works by activating three different hormone receptors: GLP-1, GIP, and glucagon
Some people report difficulty sleeping during the early weeks of treatment, which can further contribute to tiredness and decreased energy
Microneedle patches are experimental : while research exists, none have FDA approval for delivering weight-loss peptides
A syringe-shaped amps and a mask pack which is insensible and absorbable
US$ 28.46
US$ 23.96
US$ 26.70
